Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group.
Pols HA, Felsenberg D, Hanley DA, Stepán J, Muñoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B. Pols HA, et al. Among authors: vandormael k. Osteoporos Int. 1999;9(5):461-8. doi: 10.1007/pl00004171. Osteoporos Int. 1999. PMID: 10550467 Clinical Trial.
The effect of alendronate on bone mass after distal forearm fracture.
van der Poest Clement E, Patka P, Vandormael K, Haarman H, Lips P. van der Poest Clement E, et al. Among authors: vandormael k. J Bone Miner Res. 2000 Mar;15(3):586-93. doi: 10.1359/jbmr.2000.15.3.586. J Bone Miner Res. 2000. PMID: 10750574 Free article. Clinical Trial.
Alendronate for the treatment of osteoporosis in men.
Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A. Orwoll E, et al. Among authors: vandormael k. N Engl J Med. 2000 Aug 31;343(9):604-10. doi: 10.1056/NEJM200008313430902. N Engl J Med. 2000. PMID: 10979796 Free article. Clinical Trial.
Weekly oral alendronic Acid in male osteoporosis.
Miller PD, Schnitzer T, Emkey R, Orwoll E, Rosen C, Ettinger M, Vandormael K, Daifotis A. Miller PD, et al. Among authors: vandormael k. Clin Drug Investig. 2004;24(6):333-41. doi: 10.2165/00044011-200424060-00003. Clin Drug Investig. 2004. PMID: 17516720
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J. Drake L, et al. Among authors: vandormael k. J Am Acad Dermatol. 1999 Oct;41(4):550-4. J Am Acad Dermatol. 1999. PMID: 10495374 Clinical Trial.
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
Barrios V, Amabile N, Paganelli F, Chen JW, Allen C, Johnson-Levonas AO, Massaad R, Vandormael K. Barrios V, et al. Among authors: vandormael k. Int J Clin Pract. 2005 Dec;59(12):1377-86. doi: 10.1111/j.1368-5031.2005.00714.x. Int J Clin Pract. 2005. PMID: 16351668 Clinical Trial.
Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C. Reckless JP, et al. Among authors: vandormael k. Int J Clin Pract. 2008 Apr;62(4):539-54. doi: 10.1111/j.1742-1241.2008.01697.x. Epub 2008 Feb 11. Int J Clin Pract. 2008. PMID: 18266852 Clinical Trial.
32 results